EHI
Eagle Health Investments Portfolio holdings
AUM
$405M
This Quarter Return
-2.16%
1 Year Return
+14.19%
3 Year Return
+134.25%
5 Year Return
–
10 Year Return
–
AUM
$410M
AUM Growth
+$410M
(+30%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
25.76%
Top 10 Holdings %
Top 10 Hldgs %
61.88%
Holding
29
New
2
Increased
18
Reduced
2
Closed
1
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$12.4M |
| 2 |
United Therapeutics
UTHR
|
$12M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$11.6M |
| 4 |
CANO
Cano Health, Inc.
CANO
|
$11.3M |
| 5 |
AstraZeneca
AZN
|
$9.44M |
Top Sells
| 1 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$8.2M |
| 2 |
DexCom
DXCM
|
$1.5M |
| 3 |
Outset Medical
OM
|
$175K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Humana
HUM
$36.5B
| $36.5M | 8.89% |
78,621
+10,100
| +15% | +$4.68M |
|
|
2
AstraZeneca
AZN
$248B
| $35.6M | 8.68% |
611,665
+162,100
| +36% | +$9.44M |
|
|
3
United Therapeutics
UTHR
$13.8B
| $33.2M | 8.08% |
153,438
+55,400
| +57% | +$12M |
|
4
IQVIA
IQV
$32.4B
| $28.1M | 6.85% |
99,577
+18,400
| +23% | +$5.19M |
|
5
argenx
ARGX
$43.6B
| $21.8M | 5.32% |
62,332
+8,700
| +16% | +$3.05M |
|
6
Adaptive Biotechnologies
ADPT
$2.01B
| $21.1M | 5.13% |
750,760
+309,294
| +70% | +$8.68M |
|
|
BPMC
7
DELISTED
Blueprint Medicines
BPMC
| $20.6M | 5.03% |
192,639
+16,464
| +9% | +$1.76M |
|
8
Natera
NTRA
$23.1B
| $19.8M | 4.82% |
211,694
+47,200
| +29% | +$4.41M |
|
9
Alnylam Pharmaceuticals
ALNY
$58.5B
| $19.3M | 4.7% |
113,702
+23,600
| +26% | +$4M |
|
|
10
Vertex Pharmaceuticals
VRTX
$100B
| $18M | 4.4% |
82,144
+52,600
| +178% | +$11.6M |
|
11
Inspire Medical Systems
INSP
$2.77B
| $17.5M | 4.27% |
76,253
+7,600
| +11% | +$1.75M |
|
|
CANO
12
DELISTED
Cano Health, Inc.
CANO
| $17.4M | 4.23% |
1,947,779
+1,271,367
| +188% | +$11.3M |
|
|
13
Outset Medical
OM
$247M
| $15.2M | 3.69% |
329,000
-3,800
| -1% | -$175K |
|
|
AXNX
14
DELISTED
Axonics, Inc. Common Stock
AXNX
| $14.4M | 3.5% |
256,465
+66,100
| +35% | +$3.7M |
|
|
15
DexCom
DXCM
$29.5B
| $14.3M | 3.49% |
26,700
-2,800
| -9% | -$1.5M |
|
16
Agios Pharmaceuticals
AGIO
$2.19B
| $14.2M | 3.46% |
431,413
+195,900
| +83% | +$6.44M |
|
17
American Well
AMWL
$111M
| $13.6M | 3.31% |
2,247,908
+1,346,608
| +149% | +$8.13M |
|
|
SGEN
18
DELISTED
Seagen Inc. Common Stock
SGEN
| $12.4M | 3.03% |
+80,500
| New | +$12.4M |
|
19
Guardant Health
GH
$8.41B
| $11.9M | 2.91% |
119,360
+23,700
| +25% | +$2.37M |
|
|
MRTX
20
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $7.63M | 1.86% |
52,000
| – | – |
|
|
CMAX
21
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $5.49M | 1.34% |
714,755
+97,985
| +16% | +$752K |
|
22
4D Molecular Therapeutics
FDMT
$288M
| $2.9M | 0.71% |
132,090
+75,000
| +131% | +$1.65M |
|
23
Kymera Therapeutics
KYMR
$2.95B
| $2.35M | 0.57% |
37,000
| – | – |
|
24
Beam Therapeutics
BEAM
$1.66B
| $2.3M | 0.56% |
+28,900
| New | +$2.3M |
|
25
Arvinas
ARVN
$568M
| $1.89M | 0.46% |
23,000
| – | – |
|